Mergers & Acquisitions - Mergers & Acquisitions, Generics, Cardio-vascular

Sanofi buys Colombian drugmaker; Presents encouraging eliglustat and Lyxumia data; Revizes deal with B-MS


In what turns out to be a very busy couple of days for French drug major Sanofi (Euronext: SAN), the…

AvaproBiotechnologyBristol-Myers SquibbCardio-vascularDiabeteseliglustatGenericsGenfar SAGlobalLyxumiaMarkets & MarketingMergers & AcquisitionsPharmaceuticalPlavixRare diseasesResearchSanofiSouth America

Mylan gets OK for generic Crestor in Canada; Rottapharm deal looks dead


The Canadian subsidiary of US generic drugmaker Mylan (Nasdaq: MYL) has received approval from Health…

AstraZenecaCardio-vascularCrestorEuropeGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaPharmaceuticalRegulationRottapharm

Hikma adds to stake in Promopharm; gets US appro for argatroban


Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

Back to top